MyCelx Technologies (GB:MYX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
MyCelx Technologies Corporation has reported a revenue increase to $10.9 million in 2023, up from $10 million in 2022, despite a decrease in gross profit and cash reserves. The company sold its Saudi operations for $3.125 million with additional future considerations, refocusing on its PFAS and REGEN technologies. With the EPA’s new PFAS Drinking Water regulations and growing EOR market demand, MyCelx remains optimistic about its strategic partnerships and project pipeline for 2024.
For further insights into GB:MYX stock, check out TipRanks’ Stock Analysis page.
